Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robertson, K. A.
Right arrow Articles by Kelley, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, K. A.
Right arrow Articles by Kelley, M. R.
[Cancer Research 61, 2220-2225, March 1, 2001]
© 2001 American Association for Cancer Research

Tumor Biology

Altered Expression of Ape1/ref-1 in Germ Cell Tumors and Overexpression in NT2 Cells Confers Resistance to Bleomycin and Radiation1

Kent A. Robertson, Heather A. Bullock, Yi Xu, Renee Tritt, Erika Zimmerman, Thomas M. Ulbright, Richard S. Foster, Lawrence H. Einhorn and Mark R. Kelley2

Herman B. Wells Center for Pediatric Research, Departments of Pediatrics [K. A. R., H. A. B., Y. X., R. T., E. Z., M. R. K.], Biochemistry and Molecular Biology [M. R. K.], Pathology [T. M. U.], Medicine [L. H. E.], and Urology [R. S. F.], James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana 46202

The human AP endonuclease (Ape1 or ref-1) DNA base excision repair (BER) enzyme is a multifunctional protein that has an impact on a wide variety of important cellular functions including oxidative signaling, transcription factor regulation, and cell cycle control. It acts on mutagenic AP (baseless) sites in DNA as a critical member of the DNA BER repair pathway. Moreover, Ape1/ref-1 stimulates the DNA-binding activity of transcription factors (Fos-Jun, nuclear factor-{kappa}B, Myb, ATF/cyclic AMP-responsive element binding protein family, HIF-1{alpha}, HLF, PAX, and p53) through a redox mechanism and thus represents a novel component of signal transduction processes that regulate eukaryotic gene expression. Ape1/ref-1 has also been shown to be closely linked to apoptosis associated with thioredoxin, and altered levels of Ape1/ref-1 have been found in some cancers. In a pilot study, we have examined Ape1/ref-1 expression by immunohistochemistry in sections of germ cell tumors (GCTs) from 10 patients with testicular cancer of various histologies including seminomas, yolk sac tumors, and malignant teratomas. Ape1/ref-1 was expressed at relatively high levels in the tumor cells of nearly all sections. We hypothesized that elevated expression of Ape1/ref-1 is responsible in part for the resistance to therapeutic agents. To answer this hypothesis, we overexpressed the Ape1/ref-1 cDNA in the GCT cell line NT2/D1 using retroviral gene transduction with the vector LAPESN. Using an oligonucleotide cleavage assay and immunohistochemistry to assess Ape1/ref-1 repair activity and expression, respectively, we found that the repair activity and relative Ape1/ref-1 expression in GCT cell lines are directly related. NT2/D1 cells transduced with Ape1/ref-1 exhibited 2-fold higher AP endonuclease activity in the oligonucleotide cleavage assay, and this was reflected in a 2–3-fold increase in protection against bleomycin. Lesser protection was observed with {gamma}-irradiation. We conclude that: (a) Ape1/ref-1 is expressed at relatively high levels in some GCTs; (b) elevated expression of Ape1/ref-1 in testicular cancer cell lines results in resistance to certain therapeutic agents; and (c) Ape1/ref-1 expression in GCT cell lines determined by immunohistochemistry and repair activity assays parallels the level of protection from bleomycin. We further hypothesize that elevated Ape1/ref-1 levels observed in human testicular cancer may be related to their relative resistance to therapy and may serve as a diagnostic marker for refractory disease. To our knowledge, this is the first example of overexpressing Ape1/ref-1 in a mammalian system resulting in enhanced protection to DNA-damaging agents.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
Y. Jiang, C. Guo, M. R. Vasko, and M. R. Kelley
Implications of Apurinic/Apyrimidinic Endonuclease in Reactive Oxygen Signaling Response after Cisplatin Treatment of Dorsal Root Ganglion Neurons
Cancer Res., August 1, 2008; 68(15): 6425 - 6434.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. Zaky, C. Busso, T. Izumi, R. Chattopadhyay, A. Bassiouny, S. Mitra, and K. K. Bhakat
Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage
Nucleic Acids Res., March 1, 2008; 36(5): 1555 - 1566.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
L. A. Seiple, J. H. Cardellina II, R. Akee, and J. T. Stivers
Potent Inhibition of Human Apurinic/Apyrimidinic Endonuclease 1 by Arylstibonic Acids
Mol. Pharmacol., March 1, 2008; 73(3): 669 - 677.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
H. Fung, P. Liu, and B. Demple
ATF4-Dependent Oxidative Induction of the DNA Repair Enzyme Ape1 Counteracts Arsenite Cytotoxicity and Suppresses Arsenite-Mediated Mutagenesis
Mol. Cell. Biol., December 15, 2007; 27(24): 8834 - 8847.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. J. Raffoul, S. Banerjee, V. Singh-Gupta, Z. E. Knoll, A. Fite, H. Zhang, J. Abrams, F. H. Sarkar, and G. G. Hillman
Down-regulation of Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Expression by Soy Isoflavones Enhances Prostate Cancer Radiotherapy In vitro and In vivo
Cancer Res., March 1, 2007; 67(5): 2141 - 2149.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. D. Kennedy and A. D. D'Andrea
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
J. Clin. Oncol., August 10, 2006; 24(23): 3799 - 3808.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Yang, K. Irani, S. E. Heffron, F. Jurnak, and F. L. Meyskens Jr.
Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor
Mol. Cancer Ther., December 1, 2005; 4(12): 1923 - 1935.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
I.-Y. Chang, S.-H. Kim, H.-J. Cho, D. Y. Lee, M.-H. Kim, M.-H. Chung, and H. J. You
Human AP endonuclease suppresses DNA mismatch repair activity leading to microsatellite instability
Nucleic Acids Res., September 7, 2005; 33(16): 5073 - 5081.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. C. Sak, P. Harnden, C. F. Johnston, A. B. Paul, and A. E. Kiltie
APE1 and XRCC1 Protein Expression Levels Predict Cancer-Specific Survival Following Radical Radiotherapy in Bladder Cancer
Clin. Cancer Res., September 1, 2005; 11(17): 6205 - 6211.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
N. Sarkar, S. Lemaire, D. Wu-Scharf, E. Issakidis-Bourguet, and H. Cerutti
Functional Specialization of Chlamydomonas reinhardtii Cytosolic Thioredoxin h1 in the Response to Alkylation-Induced DNA Damage
Eukaryot. Cell, February 1, 2005; 4(2): 262 - 273.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Sossou, C. Flohr-Beckhaus, I. Schulz, F. Daboussi, B. Epe, and J. P. Radicella
APE1 overexpression in XRCC1-deficient cells complements the defective repair of oxidative single strand breaks but increases genomic instability
Nucleic Acids Res., January 12, 2005; 33(1): 298 - 306.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Wang, M. Luo, and M. R. Kelley
Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: Enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition
Mol. Cancer Ther., June 1, 2004; 3(6): 679 - 686.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Aouida, N. Page, A. Leduc, M. Peter, and D. Ramotar
A Genome-Wide Screen in Saccharomyces cerevisiae Reveals Altered Transport As a Mechanism of Resistance to the Anticancer Drug Bleomycin
Cancer Res., February 1, 2004; 64(3): 1102 - 1109.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Hedley, M. Pintilie, J. Woo, T. Nicklee, A. Morrison, D. Birle, A. Fyles, M. Milosevic, and R. Hill
Up-Regulation of the Redox Mediators Thioredoxin and Apurinic/Apyrimidinic Excision (APE)/Ref-1 in Hypoxic Microregions of Invasive Cervical Carcinomas, Mapped Using Multispectral, Wide-Field Fluorescence Image Analysis
Am. J. Pathol., February 1, 2004; 164(2): 557 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. M. Ordway, D. Eberhart, and T. Curran
Cysteine 64 of Ref-1 Is Not Essential for Redox Regulation of AP-1 DNA Binding
Mol. Cell. Biol., June 15, 2003; 23(12): 4257 - 4266.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
F. Mayer, F. Honecker, L. H. J. Looijenga, and C. Bokemeyer
Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors
Ann. Onc., June 1, 2003; 14(6): 825 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. L. Fishel, Y. R. Seo, M. L. Smith, and M. R. Kelley
Imbalancing the DNA Base Excision Repair Pathway in the Mitochondria; Targeting and Overexpressing N-Methylpurine DNA Glycosylase in Mitochondria Leads to Enhanced Cell Killing
Cancer Res., February 1, 2003; 63(3): 608 - 615.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. W. George, R. S. Foster, R. A. Hromas, K. A. Robertson, G. H. Vance, T. M. Ulbright, T. A. Gobbett, D. J. Heiber, N. A. Heerema, H. C. Ramsey, et al.
Update on Late Relapse of Germ Cell Tumor: A Clinical and Molecular Analysis
J. Clin. Oncol., January 1, 2003; 21(1): 113 - 122.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
H.-D. Junker, S. T. Hoehn, R. C. Bunt, V. Marathius, J. Chen, C. J. Turner, and J. Stubbe
Synthesis, characterization and solution structure of tethered oligonucleotides containing an internal 3'-phosphoglycolate, 5'-phosphate gapped lesion
Nucleic Acids Res., December 15, 2002; 30(24): 5497 - 5508.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
W. Wu, D. E. Vanderwall, C. J. Turner, S. Hoehn, J. Chen, J. W. Kozarich, and J. Stubbe
Solution structure of the hydroperoxide of Co(III) phleomycin complexed with d(CCAGGCCTGG)2: evidence for binding by partial intercalation
Nucleic Acids Res., November 15, 2002; 30(22): 4881 - 4891.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Sanz, L. Mir, and A. Jacquemin-Sablon
Bleomycin Resistance in Mammalian Cells Expressing a Genetic Suppressor Element Derived from the SRPK1 Gene
Cancer Res., August 1, 2002; 62(15): 4453 - 4458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. S. Bobola, A. Blank, M. S. Berger, B. A. Stevens, and J. R. Silber
Apurinic/Apyrimidinic Endonuclease Activity Is Elevated in Human Adult Gliomas
Clin. Cancer Res., November 1, 2001; 7(11): 3510 - 3518.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.